|
2025
|
Invention
|
Method for inducing tumor regression.
Methods for treating cancer and/or inducing tumor regressi... |
|
|
Invention
|
Bromocriptine formulations.
The present disclosure describes pharmaceutical formulations of brom... |
|
2024
|
Invention
|
Method for inducing tumor regression. Methods for treating cancer and/or inducing tumor regressio... |
|
2023
|
Invention
|
Treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Methods and com... |
|
|
Invention
|
Bromocriptine formulations. The present disclosure describes pharmaceutical formulations of bromo... |
|
|
Invention
|
Composition and method for treating metabolic disorders.
Bromocriptine citrate administered to a... |
|
|
Invention
|
Bromocriptine formulations.
The present application describes pharmaceutical formulations of bro... |
|
2022
|
Invention
|
Methods for identifying responders to dopaminergic neuronal enhancing therapies for the treatment... |
|
|
Invention
|
Compositions and methods for treating metabolic disorders.
The application discloses methods and... |
|
2021
|
Invention
|
Parenteral formulations of dopamine agonists.
This invention relates to stable pharmaceutical co... |
|
|
Invention
|
Bromocriptine formulations. The present application describes pharmaceutical formulations of brom... |
|
|
P/S
|
Action sports apparel, namely, pants, shorts, shirts, T-shirts, long sleeve shirts, sports perfor... |
|
|
Invention
|
Composition and method for treating metabolic disorders. Bromocriptine citrate administered to a ... |
|
2020
|
Invention
|
Method of treating metabolic disorders and depression with dopamine receptor agonists. This inven... |
|
2018
|
Invention
|
Improved bromocriptine formulations. The present disclosure describes pharmaceutical formulations... |
|
|
Invention
|
Methods of treating metabolic syndrome using dopamine receptor agonists.
The present invention i... |
|
|
P/S
|
Action sports apparel, namely, pants, shorts, jeans, shirts, T-shirts, long sleeve shirts, jersey... |
|
|
Invention
|
Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of meta... |
|
2017
|
Invention
|
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes.
The pres... |
|
2016
|
Invention
|
Parenteral formulations of dopamine agonists. This invention relates to stable pharmaceutical com... |
|
|
P/S
|
Pharmaceutical drug and clinical therapy development services and biological sciences research an... |
|
|
Invention
|
Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorder... |
|
2014
|
Invention
|
Compositions and methods for treating metabolic disorders. The application discloses methods and ... |
|
2011
|
Invention
|
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity or prediabetes.
The prese... |
|
2010
|
P/S
|
pharmaceutical preparations for the treatment of metabolic disorders and diseases caused by diabe... |
|
|
P/S
|
Treatment of obesity, lipid disorders, metabolic disorders, cardiovascular diseases, diseases of ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of diabetes, obesity, ... |
|
2002
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes |
